Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03-1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks
Venous thromboembolism (VTE) is a chronic disease. Strategies to assess groups at a high risk of rec...
BACKGROUND: Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associ...
BACKGROUND: We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
Patients with autoimmune disorders are at an increased risk of venous thromboembolism (VTE), but thi...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
BACKGROUND: Multiple studies have described a higher incidence of venous thromboembolism (VTE) in pe...
Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associated with a ...
AbstractObjective: Superficial thrombophlebitis (ST) is a frequent and potentially serious disease i...
We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked b...
BACKGROUND: Some autoimmune disorders have been linked to venous thromboembolism. We examined whethe...
BACKGROUND: Recurrence risk of systemic lupus erythematosus (SLE)-associated venous thromboembolism ...
Venous thromboembolism (VTE) is a chronic disease. Strategies to assess groups at a high risk of rec...
BACKGROUND: Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associ...
BACKGROUND: We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
Patients with autoimmune disorders are at an increased risk of venous thromboembolism (VTE), but thi...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
BACKGROUND: Multiple studies have described a higher incidence of venous thromboembolism (VTE) in pe...
Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associated with a ...
AbstractObjective: Superficial thrombophlebitis (ST) is a frequent and potentially serious disease i...
We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked b...
BACKGROUND: Some autoimmune disorders have been linked to venous thromboembolism. We examined whethe...
BACKGROUND: Recurrence risk of systemic lupus erythematosus (SLE)-associated venous thromboembolism ...
Venous thromboembolism (VTE) is a chronic disease. Strategies to assess groups at a high risk of rec...
BACKGROUND: Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associ...
BACKGROUND: We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE...